Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitavastatin and Ezetimibe Combination in Primary Hypercholesterolemia
NCT04584736Phase 3Completed
- Sponsor
- JW Pharmaceutical Corporation
- Start
- Jun 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pitavastatin, ezetimibe in hypercholesterolemia, sponsored by JW Pharmaceutical Corporation. Started Jun 2019; status: completed.
02
Drugs
pitavastatinezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT04584736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04584736.